Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stem Cell Research

  Free Subscription


Articles published in Exp Hematol

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    April 2019
  1. MATTES K, Geugien M, Korthuis PM, Brouwers-Vos AZ, et al
    The transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
    Exp Hematol. 2019 Apr 12. pii: S0301-472X(19)30133.
    PubMed     Text format     Abstract available


    March 2019
  2. KOHARA H, Utsugisawa T, Sakamoto C, Hirose L, et al
    KLF1 Mutation E325K Induces Cell-cycle Arrest in Erythroid Cells Differentiated from Congenital Dyserythropoietic Anemia (CDA) Patient-specific Induced Pluripotent Stem Cells.
    Exp Hematol. 2019 Mar 12. pii: S0301-472X(19)30128.
    PubMed     Text format     Abstract available


    February 2019
  3. MONTEL-HAGEN A, Crooks GM
    Special issue on pluripotent stem cells and hematopoiesis.
    Exp Hematol. 2019 Feb 12. pii: S0301-472X(19)30064.
    PubMed     Text format    


  4. COUBAN S, Wong PC, Schultz KR
    The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation.
    Exp Hematol. 2019;70:1-9.
    PubMed     Text format     Abstract available


  5. LI B, Zhu X, Ward CM, Starlard-Davenport A, et al
    MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease.
    Exp Hematol. 2019;70:85-96.
    PubMed     Text format     Abstract available


    January 2019
  6. KARAGIANNIS P, Yamanaka S, Saito MK
    Application of induced pluripotent stem cells to primary immunodeficiency diseases.
    Exp Hematol. 2019 Jan 18. pii: S0301-472X(19)30058.
    PubMed     Text format     Abstract available


  7. TURHAN AG, Foudi A, Hwang JW, Desterke C, et al
    MODELING MALIGNANCIES USING INDUCED PLURIPOTENT STEM CELLS: FROM CHRONIC MYELOID LEUKEMIA (CML) TO HEREDITARY CANCERS.
    Exp Hematol. 2019 Jan 16. pii: S0301-472X(19)30008.
    PubMed     Text format     Abstract available


  8. CHAO MP, Majeti R
    Induced pluripotent stem cell modeling of malignant hematopoiesis.
    Exp Hematol. 2019 Jan 16. pii: S0301-472X(19)30007.
    PubMed     Text format     Abstract available


  9. LIN YH, Forster M, Liang Y, Yu M, et al
    USP44 is dispensable for normal hematopoietic stem cell function, lymphocyte development, and B cell mediated immune response in a mouse model.
    Exp Hematol. 2019 Jan 9. pii: S0301-472X(19)30006.
    PubMed     Text format     Abstract available


  10. DANNENMANN B, Zahabi A, Mir P, Oswald B, et al
    Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34(+) cells preceding leukemic transformation.
    Exp Hematol. 2019 Jan 4. pii: S0301-472X(19)30004.
    PubMed     Text format     Abstract available


  11. BERNARREGGI D, Pouyanfard S, Kaufman DS
    Development of innate immune cells from human pluripotent stem cells.
    Exp Hematol. 2019 Jan 3. pii: S0301-472X(19)30003.
    PubMed     Text format     Abstract available


  12. KURITA R, Funato K, Abe T, Watanabe Y, et al
    Establishment and characterization of immortalized erythroid progenitor cell lines derived from a common cell source.
    Exp Hematol. 2019;69:11-16.
    PubMed     Text format     Abstract available


  13. ARTHUR A, Nguyen TM, Paton S, Zannettino ACW, et al
    Loss of EfnB1 in the osteogenic lineage compromises their capacity to support hematopoietic stem/progenitor cell maintenance.
    Exp Hematol. 2019;69:43-53.
    PubMed     Text format     Abstract available


  14. WU Z, Giudice V, Chen J, Sun W, et al
    Interleukin-18 plays a dispensable role in murine and likely also human bone marrow failure.
    Exp Hematol. 2019;69:54-64.
    PubMed     Text format     Abstract available


  15. IN 'T HOUT FEM, van Duren J, Monteferrario D, Brinkhuis E, et al
    TCF4 promotes erythroid development.
    Exp Hematol. 2019;69:17-21.
    PubMed     Text format     Abstract available


    December 2018
  16. GUILLAUME T, Dehame V, Chevallier P, Peterlin P, et al
    Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies.
    Exp Hematol. 2018 Dec 26. pii: S0301-472X(18)30987.
    PubMed     Text format     Abstract available


  17. ZHAN H, Kaushansky K
    Functional interdependence of hematopoietic stem cells and their niche in oncogene promotion of myeloproliferative neoplasms: The 159(th) biomedical version of "It takes two to tango".
    Exp Hematol. 2018 Dec 26. pii: S0301-472X(18)30989.
    PubMed     Text format     Abstract available


  18. MONTEL-HAGEN A, Crooks GM
    From Pluripotent Stem Cells to T cells.
    Exp Hematol. 2018 Dec 24. pii: S0301-472X(18)30986.
    PubMed     Text format     Abstract available


  19. RADTKE S, Chan YY, Sippel TR, Kiem HP, et al
    MISTRG mice support engraftment and assessment of nonhuman primate hematopoietic stem and progenitor cells.
    Exp Hematol. 2018 Dec 24. pii: S0301-472X(18)30988.
    PubMed     Text format     Abstract available


    October 2018
  20. MILLER LH, Qu CK, Pauly M
    Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis.
    Exp Hematol. 2018;66:17-26.
    PubMed     Text format     Abstract available


  21. SALOME M, Hopcroft L, Keeshan K
    Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis.
    Exp Hematol. 2018;66:63-78.
    PubMed     Text format     Abstract available


    September 2018
  22. SENFT D, Jeremias I
    A rare subgroup of leukemia stem cells harbours relapse-inducing potential in acute lymphoblastic leukemia.
    Exp Hematol. 2018 Sep 24. pii: S0301-472X(18)30807.
    PubMed     Text format     Abstract available


  23. DOESCHER A, Casper J, Kraemer D, Kapels HH, et al
    Platelet engraftment after allogenic stem cell transplantation is monitored by digital PCR without interference by platelet support.
    Exp Hematol. 2018 Sep 6. pii: S0301-472X(18)30796.
    PubMed     Text format     Abstract available


    August 2018
  24. GAO S, Zhou B, Li H, Huang X, et al
    Long non-coding RNA HOTAIR promotes the self-renewal of leukemia stem cell through epigenetic silencing of p15.
    Exp Hematol. 2018 Aug 30. pii: S0301-472X(18)30752.
    PubMed     Text format     Abstract available


  25. ELAHI S, Egan SM, Holling GA, Kandefer RL, et al
    The RNA binding protein Ars2 supports hematopoiesis at multiple levels.
    Exp Hematol. 2018;64:45-58.
    PubMed     Text format     Abstract available


    July 2018
  26. GRACE CS, Mikkola HKA, Dou DR, Calvanese V, et al
    Protagonist or antagonist? The complex roles of retinoids in the regulation of hematopoietic stem cells and their specification from pluripotent stem cells.
    Exp Hematol. 2018 Jul 4. pii: S0301-472X(18)30620.
    PubMed     Text format     Abstract available


  27. SI S, Nakajima-Takagi Y, Iga T, Tsuji M, et al
    Hematopoietic insults damage bone marrow niche by activating p53 in vascular endothelial cells.
    Exp Hematol. 2018;63:41-51.
    PubMed     Text format     Abstract available


  28. LI Y, Liu D, Zhang X, Li Z, et al
    miR-326 regulates HbF synthesis by targeting EKLF in human erythroid cells.
    Exp Hematol. 2018;63:33-40.
    PubMed     Text format     Abstract available


    June 2018
  29. YASMINE L, Geoffroy V, Laure F, Celine B, et al
    A transcriptomic signature predicting septic outcome in patients undergoing autologous stem cell transplantation.
    Exp Hematol. 2018 Jun 7. pii: S0301-472X(18)30285.
    PubMed     Text format     Abstract available


  30. GALAT Y, Elcheva I, Dambaeva S, Katukurundage D, et al
    "Application of Small Molecule CHIR99021 Leads to the Loss of Hemangioblast Progenitor and Increased Hematopoiesis of Human Pluripotent Stem Cells".
    Exp Hematol. 2018 Jun 4. pii: S0301-472X(18)30273.
    PubMed     Text format     Abstract available


  31. CAPONE S, Connor KM, Colombo A, Li X, et al
    Senescent human hematopoietic progenitors show elevated expression of transposable elements and inflammatory genes.
    Exp Hematol. 2018;62:33-38.
    PubMed     Text format     Abstract available


  32. UCHIDA N, Haro-Mora JJ, Demirci S, Fujita A, et al
    High-level embryonic globin production with efficient erythroid differentiation from a K562 erythroleukemia cell line.
    Exp Hematol. 2018;62:7-16.
    PubMed     Text format     Abstract available


    May 2018
  33. ITO K, Ito K
    Hematopoietic stem cell fate through metabolic control.
    Exp Hematol. 2018 May 25. pii: S0301-472X(18)30265.
    PubMed     Text format     Abstract available


  34. DE KRUIJF EFM, Zuijderduijn R, Stip MC, Fibbe WE, et al
    Mesenchymal stromal cells induce a permissive state in the bone marrow that enhances G-CSF-induced hematopoietic stem cell mobilization in mice.
    Exp Hematol. 2018 May 15. pii: S0301-472X(18)30258.
    PubMed     Text format     Abstract available


  35. SHI X, Kitano A, Jiang Y, Luu V, et al
    Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells.
    Exp Hematol. 2018 May 8. pii: S0301-472X(18)30256.
    PubMed     Text format     Abstract available


    April 2018
  36. WILKINSON AC, Morita M, Nakauchi H, Yamazaki S, et al
    Branched-chain amino acid depletion conditions bone marrow for hematopoietic stem cell transplantation avoiding amino acid imbalance-associated toxicity.
    Exp Hematol. 2018 Apr 26. pii: S0301-472X(18)30173.
    PubMed     Text format     Abstract available


  37. KHORAMIAN TUSI B, Socolovsky M
    High-throughput single-cell fate potential assay of murine hematopoietic progenitors in vitro.
    Exp Hematol. 2018;60:21-29.
    PubMed     Text format     Abstract available


  38. LI Y, Zhu S, Zhang Y, Liu T, et al
    High fat diet-induced obesity exacerbates hematopoiesis deficiency and cytopenia caused by 5-fluorouracil via peroxisome proliferator-activated receptor gamma.
    Exp Hematol. 2018;60:30-39.
    PubMed     Text format     Abstract available


    March 2018
  39. SINHA S, Chatterjee SS, Biswas M, Nag A, et al
    SWI/SNF subunit expression heterogeneity in human aplastic anemia stem/progenitors.
    Exp Hematol. 2018 Mar 26. pii: S0301-472X(18)30163.
    PubMed     Text format     Abstract available


  40. KURKEWICH JL, Boucher A, Klopfenstein N, Baskar R, et al
    The mirn23a and mirn23b microrna clusters are necessary for proper hematopoietic progenitor cell production and differentiation.
    Exp Hematol. 2018;59:14-29.
    PubMed     Text format     Abstract available


  41. SERRANO-LOPEZ J, Nattamai K, Pease NA, Shephard MS, et al
    Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors.
    Exp Hematol. 2018;59:40-50.
    PubMed     Text format     Abstract available


  42. MIGLIACCIO AR
    A vicious interplay between genetic and environmental insults in the etiology of blood cancers.
    Exp Hematol. 2018;59:9-13.
    PubMed     Text format     Abstract available


    February 2018
  43. UPADHAYA S, Reizis B, Sawai CM
    New genetic tools for the in vivo study of hematopoietic stem cell function.
    Exp Hematol. 2018 Feb 28. pii: S0301-472X(18)30076.
    PubMed     Text format     Abstract available


  44. DUSSIAU C, Fontenay M
    Mechanisms underlying the heterogeneity of myelodysplastic syndromes.
    Exp Hematol. 2018;58:17-26.
    PubMed     Text format     Abstract available


    January 2018
  45. GONG Y, Zhao M, Yang W, Gao A, et al
    Megakaryocyte-derived excessive TGFbeta1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia.
    Exp Hematol. 2018 Jan 4. pii: S0301-472X(17)30909.
    PubMed     Text format     Abstract available


  46. NICE FL, Massie CE, Klampfl T, Green AR, et al
    Determination of complex subclonal structures of hematological malignancies by multiplexed genotyping of blood progenitor colonies.
    Exp Hematol. 2018;57:60-64.
    PubMed     Text format     Abstract available


  47. ALONSO-FERRERO ME, van Til NP, Bartolovic K, Mata MF, et al
    Enhancement of mouse hematopoietic stem/progenitor cell function via transient gene delivery using integration-deficient lentiviral vectors.
    Exp Hematol. 2018;57:21-29.
    PubMed     Text format     Abstract available


    December 2017
  48. HADLAND B, Yoshimoto M
    Many layers of embryonic hematopoiesis: new insights into B cell ontogeny and the origin of hematopoietic stem cells.
    Exp Hematol. 2017 Dec 26. pii: S0301-472X(17)30907.
    PubMed     Text format     Abstract available


  49. GRIESSINGER E, Vargaftig J, Horswell S, Taussig DC, et al
    Acute myeloid leukemia xenograft success prediction: saving time.
    Exp Hematol. 2017 Dec 15. pii: S0301-472X(17)30900.
    PubMed     Text format     Abstract available


  50. TOKORO Y, Yamada Y, Takayanagi SI, Hagiwara T, et al
    57R2A, a newly established monoclonal antibody against mouse GPR56, marks long-term repopulating hematopoietic stem cells.
    Exp Hematol. 2017 Dec 7. pii: S0301-472X(17)30899.
    PubMed     Text format     Abstract available


  51. KADMON CS, Landers CT, Li HS, Watowich SS, et al
    MicroRNA-22 controls interferon alpha production and erythroid maturation in response to infectious stress in mice.
    Exp Hematol. 2017;56:7-15.
    PubMed     Text format     Abstract available


    October 2017
  52. KOSE S, Aerts-Kaya F, Kopru AZ, Nemutlu E, et al
    Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta adrenergic stimulation.
    Exp Hematol. 2017 Oct 10. pii: S0301-472X(17)30813.
    PubMed     Text format     Abstract available


  53. GUNDRY MC, Dever DP, Yudovich D, Bauer DE, et al
    Technical considerations for the use of CRISPR/Cas9 in hematology research.
    Exp Hematol. 2017;54:4-11.
    PubMed     Text format     Abstract available


  54. LUCAS D, O'Leary HA, Ebert BL, Cowan CA, et al
    Utility of CRISPR/Cas9 systems in hematology research.
    Exp Hematol. 2017;54:1-3.
    PubMed     Text format     Abstract available


    September 2017
  55. WAHLESTEDT M, Bryder D
    The slippery slope of hematopoietic stem cell aging.
    Exp Hematol. 2017 Sep 21. pii: S0301-472X(17)30777.
    PubMed     Text format     Abstract available


  56. OSTRANDER EL, Koh WK, Mallaney C, Kramer AC, et al
    The GNASR201C mutation associated with clonal hematopoiesis supports transplantable hematopoietic stem cell activity.
    Exp Hematol. 2017 Sep 19. pii: S0301-472X(17)30770.
    PubMed     Text format     Abstract available


    August 2017
  57. KIM YM, Gang EJ, Kahn M
    CBP/Catenin antagonists: Targeting LSCs' Achilles heel.
    Exp Hematol. 2017;52:1-11.
    PubMed     Text format     Abstract available


    July 2017
  58. CARRETTA M, de Boer B, Jaques J, Antonelli A, et al
    Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Exp Hematol. 2017;51:36-46.
    PubMed     Text format     Abstract available


  59. GANUZA M, Hadland B, Chabot A, Li C, et al
    Murine hemogenic endothelial precursors display heterogeneous hematopoietic potential ex vivo.
    Exp Hematol. 2017;51:25-35.
    PubMed     Text format     Abstract available


    June 2017
  60. LAING AA, Harrison CJ, Gibson BES, Keeshan K, et al
    Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
    Exp Hematol. 2017 Jun 28. pii: S0301-472X(17)30237.
    PubMed     Text format     Abstract available


  61. SLOMA I, Mitjavila-Garcia M, Feraud O, Griscelli F, et al
    Whole genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia.
    Exp Hematol. 2017 Jun 7. pii: S0301-472X(17)30192.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: